Literature DB >> 16783463

Distinctive pattern of cytokine production and adhesion molecule expression in peripheral blood memory CD4+ T cells from patients with active Crohn's disease.

Jaime García de Tena1, Luis Manzano, Juan Carlos Leal, Esther San Antonio, Verónica Sualdea, Melchor Alvarez-Mon.   

Abstract

An expansion of both circulating and intestinal lamina propria CD4+ CD45RO+ T cells has been described in patients with Crohn's disease. We studied both the cytokine profile and the expression of adhesion molecules on this T-cell subset. Peripheral blood CD4+ CD45RO+ T cells from patients with Crohn's disease (n=45) were assessed by flow cytometry and RT-PCR methods. The cytokine profile was also measured in intestinal lamina propria from seven patients. They were classified according to the CDAI and the results were compared with those of patients with ulcerative colitis (n=21) and noninflammatory intestinal conditions (n=15), and healthy controls (n=39). The mean percentage of circulating CD4+ CD45RO+ T cells producing intracellular TNF was higher in active than in inactive Crohn's disease patients (p < 0.001), active (p = 0.49) and inactive ulcerative colitis (p = 0.019), and healthy controls (p =0. 017). TNF expression correlated with CDAI (p < 0.001). An increased expression of intracellular IL-2, IL-6, and IL-10 in active Crohn's disease patients was also found. CD62L was downregulated in active Crohn's disease patients while no differences were observed in CD49d and CD11a expression. Lamina propria CD4+ CD45RO+ T cells from active Crohn's disease lesions showed an increased intracellular staining of TNF, IFN-gamma, and IL-10. Both peripheral and intestinal mucosa CD4+ CD45RO+ T cells from active Crohn's disease patients show an increased production of TNF. In addition, the circulating CD4+ CD45RO+ T-cell subset expresses a pattern of adhesion molecules that promotes homing to extranodal lymphoid tissues. This T-cell subset may play a relevant role in the immunopathogenesis of Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16783463     DOI: 10.1007/s10875-006-9016-4

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  39 in total

Review 1.  Tumor necrosis factor: biology and therapeutic inhibitors.

Authors:  K A Papadakis; S R Targan
Journal:  Gastroenterology       Date:  2000-10       Impact factor: 22.682

2.  Inflammatory bowel disease.

Authors:  Jaime García de Tena; Luis Manzano Espinosa; Melchor Alvarez-Mon
Journal:  N Engl J Med       Date:  2002-12-12       Impact factor: 91.245

Review 3.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

4.  Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10.

Authors:  T Kucharzik; N Lügering; H Weigelt; M Adolf; W Domschke; R Stoll
Journal:  Clin Exp Immunol       Date:  1996-06       Impact factor: 4.330

5.  Severe chronic autoimmune thrombocytopenic purpura is associated with an expansion of CD56+ CD3- natural killer cells subset.

Authors:  J Garcia-Suarez; A Prieto; E Reyes; L Manzano; J L Merino; M Alvarez-Mon
Journal:  Blood       Date:  1993-09-01       Impact factor: 22.113

6.  Classification of inflammatory bowel disease.

Authors:  J E Lennard-Jones
Journal:  Scand J Gastroenterol Suppl       Date:  1989

Review 7.  Role of cytokines in the pathogenesis of inflammatory bowel disease.

Authors:  K A Papadakis; S R Targan
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

8.  Effector Th-1 cells with cytotoxic function in the intestinal lamina propria of patients with Crohn's disease.

Authors:  P Mariani; A Bachetoni; M D'Alessandro; D Lomanto; P Mazzocchi; V Speranza
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

9.  Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease.

Authors:  E J Breese; C A Michie; S W Nicholls; S H Murch; C B Williams; P Domizio; J A Walker-Smith; T T MacDonald
Journal:  Gastroenterology       Date:  1994-06       Impact factor: 22.682

10.  Defective in vitro gamma interferon production and elevated serum immunoreactive thymosin beta 4 levels in patients with inflammatory bowel disease.

Authors:  M G Mutchnick; H H Lee; D I Hollander; G D Haynes; D C Chua
Journal:  Clin Immunol Immunopathol       Date:  1988-04
View more
  7 in total

1.  Cytokine profiles in peripheral blood of children and adults with Crohn disease.

Authors:  Seung Pak; Nina Holland; Elizabeth A Garnett; Elizabeth Mileti; Uma Mahadevan; Rachel Beckert; Bittoo Kanwar; Melvin B Heyman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-06       Impact factor: 2.839

2.  Monocytes differentiated with GM-CSF and IL-15 initiate Th17 and Th1 responses that are contact-dependent and mediated by IL-15.

Authors:  Kristina M Harris
Journal:  J Leukoc Biol       Date:  2011-07-01       Impact factor: 4.962

3.  Molecular mechanism of interleukin-2-induced mucosal homeostasis.

Authors:  Jayshree Mishra; Christopher M Waters; Narendra Kumar
Journal:  Am J Physiol Cell Physiol       Date:  2011-11-23       Impact factor: 4.249

4.  T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles.

Authors:  Soi Cheng Law; Shayna Street; Chien-Hsiung Alan Yu; Christelle Capini; Sakoontalla Ramnoruth; Hendrik J Nel; Eline van Gorp; Claire Hyde; Kim Lau; Helen Pahau; Anthony W Purcell; Ranjeny Thomas
Journal:  Arthritis Res Ther       Date:  2012-05-17       Impact factor: 5.156

5.  Interleukin-19 impairment in active Crohn's disease patients.

Authors:  Elisabet Cantó; Esther Garcia Planella; Carlos Zamora-Atenza; Juan Camilo Nieto; Jordi Gordillo; Ma Angels Ortiz; Isidoro Metón; Elena Serrano; Esteban Vegas; Orlando García-Bosch; Cándido Juárez; Sílvia Vidal
Journal:  PLoS One       Date:  2014-04-09       Impact factor: 3.240

Review 6.  Mesenchymal Stem Cells Improve Rheumatoid Arthritis Progression by Controlling Memory T Cell Response.

Authors:  Noymar Luque-Campos; Rafael A Contreras-López; María Jose Paredes-Martínez; Maria Jose Torres; Sarah Bahraoui; Mingxing Wei; Francisco Espinoza; Farida Djouad; Roberto Javier Elizondo-Vega; Patricia Luz-Crawford
Journal:  Front Immunol       Date:  2019-04-16       Impact factor: 7.561

Review 7.  Mechanisms of T cell organotropism.

Authors:  Hongmei Fu; Eleanor Jayne Ward; Federica M Marelli-Berg
Journal:  Cell Mol Life Sci       Date:  2016-04-01       Impact factor: 9.261

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.